CELEX: 62006CA0468
Language: en
Date: 2008-09-16 00:00:00
Title: Joined Cases C-468/06 to C-478/06: Judgment of the Court (Grand Chamber) of 16 September 2008 (reference for a preliminary ruling from the Efetio Athinon — Greece) — Sot. Lelos kai Sia EE (C-468/06), Farmakemporiki AE Emporias kai Dianomis Farmakeftikon Proionton (C-469/06), Konstantinos Xidias kai Sia OE (C-470/06), Farmakemporiki AE Emporias kai Dianomis Farmakeftikon Proionton (C-471/06), Ionas Stroumsas EPE (C-472/06), Ionas Stroumsas EPE (C-473/06), Farmakapothiki Farma-Group Messinias AE (C-474/06), K.P. Marinopoulos AE Emporias kai Dianomis Farmakeftikon Proionton (C-475/06), K.P. Marinopoulos AE Emporias kai Dianomis Farmakeftikon Proionton (C-476/06), Kokkoris D. Tsanas K. EPE and Others (C-477/06), Kokkoris D. Tsanas K. EPE and Others (C-478/06) v GlaxoSmithKline AEVE Farmakeftikon Proionton, formerly Glaxowellcome AEVE (Article 82 EC — Abuse of dominant position — Pharmaceutical products — Refusal to supply wholesalers engaging in parallel exports — Ordinary orders)

22.11.2008   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 301/6
            
         Judgment of the Court (Grand Chamber) of 16 September 2008 (reference for a preliminary ruling from the Efetio Athinon — Greece) — Sot. Lelos kai Sia EE (C-468/06), Farmakemporiki AE Emporias kai Dianomis Farmakeftikon Proionton (C-469/06), Konstantinos Xidias kai Sia OE (C-470/06), Farmakemporiki AE Emporias kai Dianomis Farmakeftikon Proionton (C-471/06), Ionas Stroumsas EPE (C-472/06), Ionas Stroumsas EPE (C-473/06), Farmakapothiki Farma-Group Messinias AE (C-474/06), K.P. Marinopoulos AE Emporias kai Dianomis Farmakeftikon Proionton (C-475/06), K.P. Marinopoulos AE Emporias kai Dianomis Farmakeftikon Proionton (C-476/06), Kokkoris D. Tsanas K. EPE and Others (C-477/06), Kokkoris D. Tsanas K. EPE and Others (C-478/06) v GlaxoSmithKline AEVE Farmakeftikon Proionton, formerly Glaxowellcome AEVE
   (Joined Cases C-468/06 to C-478/06) (1)
   
   (Article 82 EC - Abuse of dominant position - Pharmaceutical products - Refusal to supply wholesalers engaging in parallel exports - Ordinary orders)
   (2008/C 301/11)
   Language of the case: Greek
   Referring court
   Efetio Athinon
   Parties to the main proceedings
   
      Applicants: Sot. Lelos kai Sia EE (C-468/06), Farmakemporiki AE Emporias kai Dianomis Farmakeftikon Proionton (C-469/06), Konstantinos Xidias kai Sia OE (C-470/06), Farmakemporiki AE Emporias kai Dianomis Farmakeftikon Proionton (C-471/06), Ionas Stroumsas EPE (C-472/06), Ionas Stroumsas EPE (C-473/06), Farmakapothiki Farma-Group Messinias AE (C-474/06), K.P. Marinopoulos AE Emporias kai Dianomis Farmakeftikon Proionton (C-475/06), K.P. Marinopoulos AE Emporias kai Dianomis Farmakeftikon Proionton (C-476/06), Kokkoris D. Tsanas K. EPE and Others (C-477/06), Kokkoris D. Tsanas K. EPE and Others (C-478/06)
   
      Defendant: GlaxoSmithKline AEVE Farmakeftikon Proionton
   Re:
   Reference for a preliminary ruling — Efetio Athinon — Interpretation of Article 82 EC — Abuse of a dominant position — Refusal of an undertaking holding a dominant position to meet fully orders placed by pharmaceutical wholesalers, with the intention of limiting their export activity and, consequently, the harm caused to it by parallel trade
   Operative part of the judgment
   Article 82 EC must be interpreted as meaning that an undertaking occupying a dominant position on the relevant market for medicinal products which, in order to put a stop to parallel exports carried out by certain wholesalers from one Member State to other Member States, refuses to meet ordinary orders from those wholesalers, is abusing its dominant position. It is for the national court to ascertain whether the orders are ordinary in the light of both the size of those orders in relation to the requirements of the market in the first Member State and the previous business relations between that undertaking and the wholesalers concerned.
   
      (1)  OJ C 20, 27.1.2007.